About Index Trending news
Analyze
Pricing
Bay City Capital

Bay City Capital

Elsewhere

Alexa global traffic share

25 Jul 2017

Kezar adds $50M to its funding tally for immunoproteasome drug

FierceBiotech
+1
18 Jul 2017
$50,000,000
Venture capital (Series C)
Aisling Capital, Rock Springs Capital, Novo A/S, +6

Menlo Therapeutics Raises $50M in Series C Financing

FinSMEs
+1
25 Jul 2016
$17,000,000
Venture capital (Series A)
NEA, Lundbeckfond Ventures, Alexandria Venture Investment, +2

Pfizer, NEA-backed rare disease startup bumps up Series A to $42M

FierceBiotech
+1
19 Aug 2014
$51,000,000
Venture capital (Series C)
06 Jan 2014
$6,800,000
Venture capital (Series A)
Buchanan Investments, ARTIS Ventures, Acadia Woods Partners, +2
09 Jul 2013
11 Jun 2013
$35,000,000
Venture capital (Series B)
20 May 2013
$12,000,000
Post-IPO equity
13 Mar 2013
$35,049,975
Venture capital (Series D)
Stata Venture Partners, Point Judith Capital, Bay City Capital
07 Mar 2013
$48,000,000
Venture capital (Series C)
20 Dec 2011
$10,000,000
Venture capital (Series B)
Aberdare Ventures, New Leaf Venture Partners, Merck Global Health Innovation Fund, +1
20 Oct 2011
$42,000,000
Venture capital (Series A)
19 Jul 2011
21 Jun 2011
07 Oct 2010
$46,000,000
Venture capital (Series D)
15 Jan 2010
19 Oct 2009
07 Oct 2009
$32,000,000
Venture capital (Series B)
Kleiner Perkins Caufield & Byers, MPM Capital, Astellas Venture Management, +2
05 Aug 2009